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Stlmmal-y 
Macrophage inflammatory protein 1 ot (MIP-lot) is a 6-8-kD, lipopolysaccharide-indudble  monocyte 
and neutrophil chemotactic protein that may be important in acute and chronic inflammation. 
The present  study determined the sequential production, source, and in vivo contribution of 
murine MIP-lot in  synchronized  Schistosoma mansoni egg pulmonary granuloma formation. 
Granulomas  were examined under conditions of primary,  secondary vigorous,  and secondary 
immunomodulated immunity. Secreted MIP-lot was measured in 24-h supernatants from intact 
granulomas (700/ml) cultured with or without soluble egg antigen (SEA). Primary granulomas 
isolated  from naive mice over  a  16-d period showed low spontaneous  MIP-lcr  production 
(<1 ng/ml). However, when primary granulomas were challenged with SEA, significant MIP-lot 
production was observed beginning at day 4 and peaking at day 16. Intact vigorous (isolated 
from 8-wk-infected mice) and modulated (isolated from 20-wk-infected mice) secondary pulmonary 
granulomas demonstrated comparable  spontaneous  MIP-lcr  production. Addition of SEA to 
vigorous stage granulomas augmented expression of MIP-lot at all time points, whereas stimulated 
modulated stage granulomas did not increase production. The latter observation is likely related 
to endogenous immunoregulatory mechanisms reported for modulated stage animals. Immuno- 
histochemical localization of MIP-lot in granuloma sections and cytocentrifuge preparations from 
vigorous lesions localized MIP-lot production to macrophages within granulomas.  Treatment 
of mice with rabbit anti-mouse MIP-lot antibodies significantly decreased 8-d primary granuloma 
formation (>40%) when compared with control mice. Anti-MIP-lc~ sera also decreased vigorous 
(>20%), but not modulated granuloma formation. These findings demonstrate that MIP-lot 
contributes to cellular recruitment during schistosome egg granuloma formation. 
T 
he recruitment of cells into an area of inflammation is a 
crucial step in the development  of delayed-type hyper- 
sensitivity responses. Presumably, the secretion ofchemokines 
contributes to the inflammatory response and is pertinent to 
the elicitation  of cells into the affected area. One cytokine 
that may be responsible for the recruitment of both neutro- 
phils and monocytes/macrophages to sites of inflammation 
is macrophage inflammatory protein-1  (MIP-1) 1 (1, 2). Na- 
tive MIP-1 is an LPS-inducible, heparin-binding protein made 
up of two 8-kD peptides, designated MIP-lot and -18, and 
is a member of the C-C chemokine supergene family (1-3). 
In vivo, the injection of the doublet can induce an acute inflam- 
matory response and prostaglandin-independent fever (2, 4). 
t Abbreviations  used in  this paper: MIP-lot,  macrophage  inflammatory 
protein lo~; SEA, soluble egg antigen. 
It is interesting that MIP-1  has been found to induce the 
production of other inflammatory cytokines, TNF-ot, IL-1, 
and IL-6 (5). 
Granuloma formation during murine schistosomiasis man- 
soni can be studied under conditions of primary,  secondary 
vigorous,  and secondary modulated immunity (6). During 
initial egg deposition (5-6 wk of infection), a primary granu- 
loma forms around eggs in response to the foreign body and 
released soluble egg antigens (SEA) (6, 7). The continuous 
deposition of eggs sensitizes the host, and, subsequently, there 
is a more rapid secondary (vigorous) response which sequesters 
the deposited egg. Vigorous granuloma formation occurs at 
8 wk of infection and accompanies peak production of inflam- 
matory cytokines (8-10). As the infection progresses, the in- 
tensity of the response wanes and there is onset of modulated 
granuloma  formation  associated  with  impaired  cytokine 
production by 20 wk (8-15). The formation of schistosome 
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ment (8,  16). First, there is an early recruitment stage fol- 
lowed by a maintenance or sustenance stage, which presum- 
ably continues until the destruction of the egg nidus. Finally, 
there is a resolution stage manifested by healing and fibrosis. 
The early cellular recruitment stage is critical for the devel- 
opment of the granuloma and likely requires  the generation 
of chemokines for the elicitation of the leukocytic infiltrate. 
The maintenance phase  would also require the generation 
of chemokines, necessary for the continued recruitment of 
cells and sustenance of the granuloma. The cytokines pro- 
duced during early stages of granuloma formation may be 
important in the initiation of granuloma development and 
determine the severity of the associated tissue damage. The 
characterization of cytokines responsible  for the recruitment 
of inflammatory cells that comprise the granuloma is essen- 
tial for elucidation of the critical mechanisms that establish 
those lesions. 
In the present study, we have determined the temporal ex- 
pression  of MIP-lol during primary and secondary S.  man- 
soni egg granuloma formation. Immunohistochemical local- 
ization  of MIP-lo~  has  identified the  macrophage  as  the 
primary source of MIP-lo~ in the developing granuloma. Fi- 
nally, in vivo neutralization of MIP-loe demonstrated the con- 
tribution of this chemokine in the formation of the granu- 
loma  during  both  the  primary  and  vigorous  secondary 
response,  but not the modulated secondary response. 
Materials  and Methods 
Animals and Infection.  Female  CBA/J mice were purchased from 
the Jackson Laboratory, (Bar Harbor, ME) and were maintained 
under standard pathogen-free conditions. 
5-8-wk-old mice were infected by percutaneous tail infection 
with 25-30 Peurto Rican strain of Schistosoma mansoni cercariae. 
Induction, Isolation, and Culture of Synchronous Pulmonary Granu- 
lomas.  Synchronous  granulomas were induced by i.v. injection of 
3,000 isolated S. mansoni eggs into normal and acutely and chroni- 
cally infected mice. Eggs trapped in the lung elicit a synchronous 
granulomatous response  indicative  of that observed within the liver 
of infected mice. Granulomas were isolated from mice 1, 2, 4, 8, 
or 16 d after embolization. Mice were killed, lungs were lavaged, 
inflated  with cold R.PMI (Gibco BRL, Gaithersburg, MD) culture 
media, and homogenized in a blender (Waring, New Hartford, 
CT). Granulomas were collected over a stainless steel mesh. The 
granulomas were cultured at 700 lesions/ml in RPMI 1640 sup- 
plemented with 10% FCS, 100 mM glutamine, 100 U/ml peni- 
cillin, and 100/~g/ml streptomycin in 60-mm culture dishes in the 
presence or absence of SEA (10/~g/ml). Culture supernatants were 
collected 24 h after stimulation and stored at -80~  until tested. 
Isolated hepatic granuloma cells were obtained from livers of 
8-wk-infected mice as previously  described (15). The cells were in- 
cubated with SEA for 24 h. Nonadherent cells were then cytocen- 
trifuged and both adherent and nonadherent cells were used in im- 
munohistochemical staining to localize MIP-lcz using the rabbit 
anti-murine  antibodies. 
Isolation  and  RT-PCR  Amplification  of  Whole-lung  mRNA. 
Whole lungs containing synchronous granulomas at different days 
of development were snap-frozen in liquid nitrogen and stored at 
-70~  Total cellular RNA from the frozen lungs was isolated 
by homogenating the lungs with a tissue homogenizer in a solu- 
tion containing 25 mM Tris, pH 8.0, 4.2 M guanidine  isothiocynate, 
0.5%  sarkosyl, and 0.1 M 2-ME. After homogenation, the sus- 
pension was added to a solution containing an equal volume of 
100 mM Tris, pH 8.0, 10 mM EDTA, and 1.0% SDS. The mixture 
was then extracted two times each with phenol-chloroform and 
chloroform-isoamyl alcohol. The RNA was alcohol precipitated 
and the pellet dissolved in DEPC water. Total RNA was deter- 
mined by spectrometric analysis at 260 nm wavelength. 5/,g of 
total RNA was reversed transcribed into cDNA utilizing an RT 
kit (GIBCO-BRL) and oligo (dT)n-ls primers. The cDNA was 
then amplified using specific primers for ~-actin as a control and 
murine MIP-lcz. The primers used were 5'-GTG-GGG-CGC-CCC- 
AGG-CAC-CA-3' and 5'-GCT-CGG-CCG-TC,  C~TGC~TGA-AGC-3' 
for fl-actin and 5'-GCC-CTT-GCT-GTT-CTT-CTC-TGT-3' and 
5'-GGC-AAT-CAG-TTC-CAG-GTC-AGT-Y for routine MIP-loe, 
giving amplified products of ~550 and 300 bp, respectively. The 
amplification  buffer contained 50 mM KC1, 10 mM Tris-HCL (pH 
8.3), and 2.5 mM MgC1. Specific  oligonucleotide  primer was added 
(200 ngAample) to the buffer, along with 1/zl of the reverse- 
transcribed cDNA samples. The cDNA was amplified after deter- 
mining the optimal number of cycles. The mixture was first in- 
cubated for 5 min at 94~  and then cycled  27 times at 95~  for 
30 s, 58~  for 45 s, and elongated at 72~  for 75 s. This format 
allowed optimal amplification with little or no nonspecific  ampli- 
fication of contaminating DNA. After amplification, the sample 
(20/~1) was separated on a 2% agarose gel containing 0.3/zg/ml 
(0.003%) of ethidium bromide, and bands visualized and pho- 
tographed using UV transillumination. 
Production of  Anti-MIP-lol Antibodies.  Rabbit anti-murine MIP- 
lc~ antibodies  were prepared by multiple-site  immunization of New 
Zealand White rabbits with recombinant murine MIP-lcx (R&D 
Systems, Inc., Minneapolis, MN) in CFA. Polyclonal antibodies 
were titered by direct ELISA and specificity  verified  by the failure 
to crossreact with mlL-lc~, mi1r  mTNF, Ib6, mJE, mMIP-I~, 
hMCP-1, hlL-8, hRANTES, hMIP-lcz, and hMIP-1B. The poly- 
clonal antibodies neutralized routine MIP-l~x-induced monocyte 
chemotaxis in vitro and were used for immunohistochemical  local- 
ization of murine MIP-lc~ in granulomas and in vivo neutraliza- 
tion of MIP-loL  experiments. Furthermore, the IgG fraction of the 
serum was purified over a protein A column and used in a sand- 
wich ELISA as previously described. 
MIP-lol ELISA.  Extracellular immunoreactive MIP-lcz was 
quantitated using a modification of a double ligand method as pre- 
viously described (17). Briefly, flat-bottomed 96-well microtiter 
plates (Immuno-Plate I 96-F; Nunc,  Roskilde, Denmark) were 
coated with 50/zl/well  of rabbit anti-MIP-lcz antibody (1 ng//zl 
in 0.6 M NaC1, 0.26 M H3BO4, and 0.08 N NaOH, pH 9.6) for 
16 h at 4~  and then washed with PBS, pH 7.5, 0.05% Tween 
20 (wash buffer). Microtiter plate nonspecific  binding sites were 
blocked with 2% BSA in PBS and incubated for 90 min at 37~ 
Plates were rinsed four times with wash buffer, and diluted (1:2 
and 1:10) cell-free supernatants in duplicate were added, followed 
by incubation for 1 h at 37~  Plates were washed four times, fol- 
lowed by the addition of 50/zl/well biotinylated rabbit anti-MIP- 
lcx antibody (3.5 ng/t~l in PBS, pH 7.5, 0.05% Tween 20, and 
2% FCS), and plates incubated for 30 min at 370C. Plates were 
washed four times, streptavidin-peroxidase conjugate (Bio-Rad 
Laboratories, Richmond, CA) added, and the plates incubated for 
30 rain at 37~  Plates were again washed four times and chro- 
mogen substrate (Bio-Rad  Laboratories)  added. The plates' reaction 
terminated with 50/~l/well of 3 M H2SO4 solution. Plates were 
read at 490 nm in an ELISA reader. Standards were one-half log 
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ELISA method consistently detected MIP-la concentrations above 
10 pg/ml. 
Imraunohistockemical Localization of  MIP-l  c~ in Synchonous Granu- 
lomas.  Paraffin-embedded  tissue sections mounted on poly-L-lysine 
slides were deparaffinized with xylene followed by stepwise rehydra- 
tion in 100, 95, 70, and 50% ethanol followed by 10 min incuba- 
tion in PBS. Cytospin preparations of dispersed granulomas were 
fixed with 4% paraformaldehyde and treated in a similar fashion 
to the tissue sections. All sections and fixed calls were blocked with 
normal  goat serum for 30 rain.  The sections were covered with 
the rabbit  anti-murine  MIP-lc~ serum diluted in PBS (1:250) for 
30 rain at 37~  After rinsing three times with PBS, the sections 
were overlaid for 20 rain with biotinylated  goat anti-rabbit IgG 
(supersensitive reagent  1:10; BioGenex Laboratories, San Ramon, 
CA). After rinsing three times with PBS, the lung sections were 
incubated for 20 min with streptavidin-atkaline phosphatase (1:20; 
BioGenex) at 37~  The slides were rinsed with PBS and overlaid 
with Fast red (BioGenex Laboratories) until color development was 
observed (15-30 rain). Sections were rinsed and counterstained with 
Mayer's hemotoxylin (Mayer & Myles Laboratories, Coopersburg, 
pA). 
Inhibition of In  Vivo Granuloma Formation with Anti-MIP-lot 
Serum.  Pulmonary granuloma formation was observed after chal- 
lenge with S. mansoni  eggs in naive, 8-wk and 20-wk-infected mice 
after treatment  with rabbit anti-routine MIP-lc~ or normal rabbit 
serum. Mice were pretreated and then treated every other day with 
0.5  ml of serum  intraperitoneally  for 8 d with the primary  and 
4 d with vigorous and modulated secondary granuloma formation. 
After 8 or 4 d, respectively, the lungs were inflated and preserved 
in 10% buffered formalin. Histological sections were stained and 
granulomas were measured with computer-assisted morphometric 
analysis. Each group contained five to six mice, and 20 granulomas 
from each lung were measured. 
Statistics.  Statistical significance was determined  by Student's 
t test  and  significance was determined  with P values <0.05. 
Results 
RT-PCR Amplification  of MIP-lcr from Pulmonary Granu- 
lomas.  We first screened granulomatous lungs for MIP-lo~ 
mRNA by isolating whole RNA at different stages of granu- 
loma development and performing RT followed by primer- 
directed PCR amplification.  Fig.  1 illustrates  that  MIP-lot 
mRNA can be detected at most points of primary and sec- 
ondary granuloma  formation.  Low signal  levels were even 
detected in normal  lungs.  During  primary granuloma  for- 
mation,  MIP-loe  mRNA  levels  were equal  to  or  slightly 
greater  than  that  of the normal  control lungs  throughout 
the time frame studied (days  1-16). During  secondary vig- 
orous granuloma formation, significantly more mRNA was 
detected throughout  the development period and as early as 
12  h  post-egg embolization.  MIP-lo~ mKNA  during  sec- 
ondary modulated granuloma formation was also upregulated 
by 12 h, but decreased at 1, 2, and 4 d with mRNA appearing 
again at days 8 and 16. These results suggested that MIP-lot 
is differentially expressed during the primary, secondary vig- 
orous,  and  secondary modulated  response. 
MIP-Icr Production  frora In Vitro Cultured Granulomas.  We 
next directly measured sequential production of MIP-lo~ by 
egg granulomas  isolated from the lungs of normal mice or 
mice at 8  (vigorous) and 20 (modulated)  wk of infection. 
Granulomas were collected at 1, 2, 4, 8, and 16 d post-egg 
challenge and were incubated in culture in the presence or 
absence of SEA (5/~g/ml)  for 24 h.  The time course study 
showed a significant increase in antigen-dicited production 
of MIP-lol as the primary granuloma  developed from 4  to 
16 d (3.7  +  0.6 to 25.9  _+  16 ng/ml,  respectively) (Fig.  2). 
Antigen-dicited production of MIP-lc~ was not detected be- 
fore day 4. 
A  different pattern  of MIP-lcx production was observed 
during the vigorous and modulated secondary response (Fig. 
3). In the absence of SEA, both vigorous and modulated granu- 
lomas produced comparable background  levels  of MIP-lc~ 
ranging  from 2.0 to 7,8 ng/ml.  However, SEA stimulation 
revealed a dear difference between the groups. SEA augmented 
production of MIP-lc~ only in the vigorous granuloma cul- 
tures. The modulated granulomas failed to show augmenta- 
tion of MIP-lc~ production with addition of SEA. Compared 
with the primary response, the vigorous granuloma MIP-lo~ 
production was accelerated peaking at day 2 (16 _+ 4.6 ng/ml) 
and only partially declining at days 4 and 8 (10.5  +  4.7 and 
8.1  +  2.5 ng/ml,  respectively). Modulated granulomas also 
showed an accelerated onset of MIP-loL production, but levels 
were consistently lower then those for vigorous lesions. Thus, 
MIP-lc~ production showed a direct correlation with the rate 
and  amplitude  of granuloma  formation. 
Imraunohistochemical Localization of  MIP-  I cr Production in Egg 
Granulomas.  To identify potential sites of MIP-loe produc- 
tion, sections of paraffin-embedded granulomatous tissue from 
normal and schistosome-infected mice were stained for MIP- 
lol immunohistochemically.  As shown in  Fig.  4,  MIP-lc~ 
is localized to mononudear cells in granulomas. These studies 
Figure  1.  Detection  ofMIP-lo~  mRNA 
by RT-PCR amplification. Whale RNA 
was isolated from lungs at different time 
points of granuloma development and re- 
verse transcribed utilizing oligo (dT)lz-ls 
primers. Specific  oligonudeotide primers 
were used to amplify  MIP-Io~  and O-actin 
using 0.2/~g total RNA equivalents. The 
reaction mixture was amplified  by 28 cycles 
each consisting of  three steps;  30 s at 95~ 
45 s at 58~  and 60 s at 72~  Repeat 
experiments demonstrated similar results. 
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Figure  2.  MIP-I~ production by isolated primary pulmonary granu- 
lomas. Isolated pulmonary granulomas (700/ml) from naive mice at var- 
ious points of development were cultured for 24 h with or without SEA. 
Culture  supernatants were collected and the level of MIP-I~ was mea- 
sured by ELISA. Data represents the mean  +  SEM of three separate ex- 
periments using different mice and separate egg harvests. 
demonstrated  a  greater  number  of cells  stained  positive in 
vigorous lesions (Fig. 4, A  and B) than in either the primary 
or  secondary modulated  granulomas  (data not  shown).  To 
further clarify the specific cell population that was producing 
MIP-lot, vigorous (8-wk) granulomas were isolated and dis- 
persed.  The  dispersed  whole  or  macrophage-depleted  (by 
plastic adherence) granulomas cells were incubated with SEA. 
Immunohistochemical localization of MIP-lot was then per- 
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Figure  3.  MIP-I~ production by isolated secondary  vigorous and modu- 
lated pulmonary granulomas. Isolated pulmonary granulomas (700/ml) 
from S. mansoni-infected mice at various points of development were cul- 
tured for 24 h with or without SEA. Culture supernatants were collected 
and the level  of  MIP-l~ was measured  by ELISA.  Data represents the mean 
_+  SEM of three separate experiments using different mice and separate 
egg harvests. 
formed on cytospin specimens of adherent  and nonadherent 
cell populations. In all cases,  the only cells that expressed MIP- 
lot was the macrophage population (Fig.  5, A-C).  In addi- 
tion,  extracellular  MIP-lot  was detected  in  cultures  of un- 
separated  secondary  vigorous  granuloma  cells  but  not 
macrophage-depleted  cultures  (1.2  ng/ml  and <0.1  ng/ml, 
Figure  4.  lmmunolocalization 
of MIP-I~ in vigorous granulomas 
from 8-wk S. mansoni-infected mice. 
Paraffin-embedded granulomatous 
tissue  was  sectioned and  stained 
using  MIP-I~ specific polyclonal 
rabbit  antiserum  (B)  or  normal 
rabbit serum (A) as a control. Re- 
peat  experiments  demonstrated 
similar patterns of staining. 
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 respectively). Taken together, these studies indicate that the 
macrophage was the primary cellular source of MIP-lc~ in 
the granuloma. 
Inhibition of  Pulmonary Egg Granulomas by Anti-MIP-Icr An- 
tisera.  To determine whether or not MIP-lot contributed 
to granuloma development, we performed in vivo neutral- 
ization studies with polyclonal rabbit anti-mouse MIP-lot 
serum. Primary granulomas were initiated in naive mice treated 
with anti-MIP-lot or control serum every other day. At 8 d, 
mice were killed and the lungs were examined histologically. 
As shown in Fig. 6, morphometric assessment of granuloma 
development demonstrated that anti-MIP-lo~  treatment at- 
tenuated granuloma formation by more than 40% (P < 0.001) 
as compared with controls (8,156  +_  587/xm  2 and 13,461 
_+  832  #m  2,  respectively).  A  representative  photomicro- 
graph (Fig.  7, A  and B) demonstrates the abrogation due 
to in vivo neutralization of MIP-lot in primary granuloma 
formation. In many lesions, nearly all of the cellular infiltra- 
tion was inhibited by the anti-MIP-lot treatment. 
We next determined whether anti-MIP-lot serum treat- 
ment could affect secondary vigorous and modulated granu- 
loma formation. In these studies, animals were treated with 
anti-MIP-lot serum at days 0 and 2, then killed at day 4. 
Depletion of MIP-lo~ significantly (P < 0.01) attenuated vig- 
orous granuloma area by >20% as compared with controls 
(24,574  _  1,249 #m  2 and 30,660  _+ 932/~m  2, respectively) 
(Fig. 6). In contrast, neutralization of MIP-lot in modulated 
granuloma formation failed to have a significant  effect on 
granuloma size as compared with infected control mice (17,997 
_+ 910 #m  2 and 18,709  +  932/zm  2, respectively). Fig. 7 il- 
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Figure  6.  Inhibition of granuloma  formation by anti-MIP-l~ rabbit 
serum.  Pulmonary granulomas  were evoked in naive (8-(t) and infected 
mice (4-d). Groups  of mice at each stage of infection  were treated with 
0.5 ml of either anti-MIP-lc~ rabbit  serum or normal rabbit serum every 
other day. Lungs were harvested and formalin fixed on the specified day 
of granuloma  formation. Histological examination  and granuloma  area 
measurements  were  accomplished  by  computer  image  analysis.  Data 
represents the mean of 20 granuloma measurements  per mouse with five 
to six mice per group from two separate experiments. 
lustrates that the degree of abrogated recruitment with vig- 
orous lesions (C and D) was not as great as in primary granu- 
loma formation, and no decrease was evident at the modulated 
stage of infection (E and F). 
Discussion 
In the present study, we have demonstrated the temporal 
expression,  cellular source, and the in vivo contribution of 
MIP-lo~ in the development of pulmonary S. mansoni egg-in- 
duced granulomas. The expression  of MIP-lo~  during the 
course of primary and secondary granuloma formation cor- 
responded to the immune status  of the host. The primary 
granuloma, which peaks in size at 8 to 16 d after emboliza- 
tion (6,  16), began expressing  detectable  MIP-lo~ at day 4 
and continued to increase through day 16. The constitutive 
levels of MIP-lc~ were much higher in the secondary vig- 
orous and modulated granulomas as compared with the pri- 
mary granulomas. The constitutive levels of MIP-lot in the 
secondary response may reflect a primed environment for the 
rapid expression of MIP-lc~ and recruitment of cells for ac- 
cderated granuloma formation around the deposited egg. The 
in vitro expression of MIP-lo~ by isolated vigorous granu- 
lomas was accelerated in response to SEA, detectable at day 
1, and peaking at day 2, with levels largely sustained at days 
4 and 8. It is interesting that the modulated granulomas ex- 
pressed background levels of MIP-lot comparable with the 
vigorous stage granulomas, however, upon stimulation with 
SEA, there was increased population of MIP-lc~ only at day 
1. In general,  the in vitro production of SEA-specific MIP- 
lo~ corresponded directly to the level of MIP-lot-specific 
mKNA as determined by RT-PCR. The decreased produc- 
tion of MIP-lc~  at the modulated stage of infection corre- 
sponds to previous reports demonstrating decreased T  cell 
function and lymphokine production (6, 8,  11-15). These 
findings, along with the antigen-specific  increases in MIP- 
lc~ at the vigorous stages in the present study would suggest 
that this cytokine is regulated in conjunction with or by T 
lymphocytes and their products. Lack of antigen-elicited MIP- 
lc~ production by intact modulated secondary granulomas 
may reflect local chemokine  regulation within the granuloma 
that would allow initial early sequestration of the egg, yet 
impair further elicitation of leukocytes to the developing 
granulomas. 
Immunohistochemical  localization of MIP-lot from intact 
granulomas, as well as dispersed granuloma cells, has identified 
the macrophage as the primary cellular source of MIP-lc~. 
This corroborates previous in vitro studies showing the mac- 
rophage as the predominant cellular source of MIP-lc~  (5). 
In addition, the dispersion of the vigorous granulomas demon- 
strated little detectable MIP-lot production by the nonad- 
herent lymphocytes and eosinophils.  The fact that MIP-lot 
could be detected by immunohistochemical  localization within 
granulomas  at  all  stages  of infection indicates  that  this 
chemokine is involved to a greater or lesser degree in the de- 
velopment of both primary and secondary granulomas. 
The contribution of MIP-lot to primary granuloma for- 
1556  Kole of MIP-lc~ in S.  Mansoni  Egg-induced  Granulomatous  Inflammation Figure 7.  Photomicrographs of granuloma formation in normal serum (A, C, and E) and anti-MIP-lo~ (B, D, and F) treated naive and infected 
mice. Illustrations are representative of the degree of inhibition in mice treated with serum in primary (A and B) and secondary vigorous (C and 
D) and modulated (E and F) granuloma formation.  Photomicrographs are of granulomas in lungs taken from data in Fig. 6. 
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of lesion area with anti-MIP-loe serum treatment. In vivo 
depletion of MIP-lot in 8-wk-infected, vigorous stage mice 
decreased granuloma area by more than 20%, demonstrating 
at least a partial role in secondary granuloma formation. The 
failure of anti-MIP-loe to impair modulated granulomas is 
consonant with their impaired MIP-lc~ production in response 
to SEA and supports the notion that MIP-lc~ is downregu- 
lated at the modulated stage. 
There may be several reasons why the anti-MIP-lc~ treat- 
ment had less effect on the vigorous lesions.  The vigorous 
granulomas produced significantly more MIP-lo~ than did 
the primary lesions, and there may have been insufficient neu- 
tralization of the MIP-lc~ at this stage. A second explanation 
may entail the production of other chemotactic factors during 
the development of secondary modulated granulomas which 
would allow the granulomatous response to continue at a 
reduced level.  Chemokines,  such  as  murine JE  (18)  and 
RANTES (19), which are both chemotactic for mononuclear 
cells, may be more prevalent during secondary granuloma for- 
mation. Finally,  the type and level of chemokines produced 
during the various stages of granuloma formation may prove 
to be pertinent to the specific population of cells recruited 
to the granuloma. The primary granuloma is characterized 
by the presence of predominantly mononuclear cells. How- 
ever, with the development of the secondary granuloma, there 
is a rapid shift in cellular constituents from mononuclear to 
predominantly eosinophils. The decreased presence of mac- 
rophages in the secondary vigorous granuloma may be in- 
dicative of the decreased role for MIP-lo~ in monocyte recruit- 
ment  as  reflected by  the reduced inhibitory effect of the 
anti-MIP-lc~ antiserum treatment. 
Our findings show that MIP-lc~ is produced in both the 
early recruitment and maintenance phases of primary and sec- 
ondary granuloma formation and is therefore a likely con- 
tributor to cellular recruitment throughout the growth of 
the granuloma. The role of MIP-lol production in the granu- 
loma may not only be limited to cellular recruitment, but 
may  also  involve  the  generation  of other  inflammatory 
cytokines, IL-1, IL-6, and TNF-ot (5).  The production of 
MIP-lol within the granuloma may result in increased cytokine 
production along with local macrophage proliferation and 
activation. TNF has recently been shown to restore granu- 
loma formation in SCID mice (20). Therefore, the increased 
production of TNF in response to MIP-lol could promote 
granuloma formation during the maintenance phase when 
TNF production has previously been detected (8). 
The present study provides the first evidence that MIP-lol 
has an important role in vivo during granuloma formation. 
The presence of MIP-lot within the granuloma may serve 
as a monocyte chemotaxin as well as an activating factor for 
infiltrating leukocytes. It is interesting that our study also 
suggests that the regulation of chemokines such as MIP-loL 
may be responsible for determining the degree and rate of 
granuloma formation. 
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